Industry News - Tag: Perrigo

You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Perrigo licenses OTC rights to Merck's Nasonex
Premium

9 August 2018

Perrigo has agreed a licensing deal for the prescription-to-OTC switch of Merck & Co's allergy medicine Nasonex Nasal Spray (mometasone furoate monohydrate) in the US. The company said the deal would create an "innovative product offering" for Perrigo, which specialises in store-brand products i...

Read the full story

Perrigo plans to focus on consumer healthcare
Premium

9 August 2018

Perrigo has announced plans to split off its Prescription Pharmaceuticals unit and focus on its two consumer healthcare businesses. The news came as Perrigo reported sales down by 5.7% at constant currencies in the second quarter of 2018.

Read the full story

Perrigo offers melt-in-your-mouth omeprazole

11 April 2018

Perrigo has extended its store-brand offering in the US with a "melt-in-your-mouth" omeprazole product for frequent heartburn. The company said the "novel" OTC product, which could be taken without water, provided "consumer-friendly dosing".

Read the full story